Two acromegalic patients suffering from severe obstructive sleep apnoea syndrome were treated with the long-acting somatostatin analogue octreotide. Daytime sleepiness and fatigue improved within a few days. Repeat sleep studies performed after octreotide treatment revealed more confluent sleep with a shorter duration of sleep apnoea. Nocturnal hypoxaemia improved in one patient. Octreotide might be an effective noninvasive treatment for sleep apnoea of acromegaly.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1365-2796.1994.tb01288.x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!